Elucidation of the regulatory mechanism of SETDB1 translocation is important for superintending its activity, as it is causally related to a variety of cancers as an oncogene (Lazaro-Camp et al., 2021) and is thus considered a promising therapeutic target for cancer immunotherapies (Griffin et al., 2021). The gene discussed is SETDB1; the disease is cancer.